Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07MQF
|
|||
| Former ID |
DNC014888
|
|||
| Drug Name |
MYRIOCIN
|
|||
| Synonyms |
Myriocin; thermozymocidin; 35891-70-4; ISP-I; ISP-1; UNII-YRM4E8R9ST; (2S,3R,4R,6E)-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid; YRM4E8R9ST; Myriocin, Mycelia sterilia; Myriocin from Mycelia sterilia; CHEBI:582124; NCGC00163597-02; NCGC00163597-03; DSSTox_CID_26360; DSSTox_RID_81561; (2S,3R,4R,6E)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid; DSSTox_GSID_46360; [2S,3R,4R]-(E)-2-Amino-3,4-dihydroxy-2-[hydroxymethyl]-14-oxo-6-eicosenoic Acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H39NO6
|
|||
| Canonical SMILES |
CCCCCCC(=O)CCCCCCC=CCC(C(C(CO)(C(=O)O)N)O)O
|
|||
| InChI |
1S/C21H39NO6/c1-2-3-4-10-13-17(24)14-11-8-6-5-7-9-12-15-18(25)19(26)21(22,16-23)20(27)28/h9,12,18-19,23,25-26H,2-8,10-11,13-16,22H2,1H3,(H,27,28)/b12-9+/t18-,19+,21+/m1/s1
|
|||
| InChIKey |
ZZIKIHCNFWXKDY-GNTQXERDSA-N
|
|||
| CAS Number |
CAS 35891-70-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
11968057, 14805891, 14854821, 24896622, 26756978, 26759208, 43031398, 49854214, 49964849, 50068838, 50111481, 53790664, 57368041, 76654310, 87283396, 87550945, 103240233, 114556016, 119501698, 124892468, 134352093, 135077382, 135626380, 137042063, 140481826, 144205615, 144206951, 162222791, 162228294, 163687643, 170466855, 175607767, 178103276, 179150375, 184596391, 198960138, 232255106, 234004305, 241065157, 243602333, 252457629, 252468170
|
|||
| ChEBI ID |
CHEBI:582124
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6664). | |||
| REF 2 | Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation. Nat Chem Biol. 2008 Sep;4(9):538-47. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.